DSGN - Company ID 0001807120
The table below shows Design Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.25M | $12.91M | $12.77M | $15.09M | $19.70M | $13.67M |
| Short-term investments | $193.36M | $194.49M | $210.05M | $190.88M | $196.57M | $216.01M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $213.96M |
| $212.01M |
| $227.05M |
| $209.03M |
| $219.79M |
| $233.64M |
| Property, plant & equipment | $573.00K | $694.00K | $824.00K | $1.10M | $1.26M | $1.38M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $216.81M | $215.13M | $230.44M | $211.77M | $222.89M | $237.47M |
| Accounts payable | $2.08M | $3.14M | $2.28M | $1.91M | $1.01M | $3.18M |
| Total current liabilities | $12.75M | $11.24M | $10.19M | $11.17M | $8.75M | $8.24M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $14.61M | $13.27M | $12.39M | $12.05M | $9.85M | $9.56M |
| Retained earnings | -$355.10M | -$334.81M | -$314.64M | -$281.01M | -$264.01M | -$244.93M |
| Total equity | $202.20M | $201.86M | $218.05M | $199.72M | $213.04M | $227.92M |